Farley J

No ORCID on file · 2 papers in corpus
nonrandomized-trial 2018
Gynecologic Oncology ·doi:10.1016/j.ygyno.2018.04.572

OBJECTIVE: To evaluate the efficacy and tolerability of cabozantinib in recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer. METHODS: Patients with recurrent ovarian, fallopian or primary peritoneal tumors with at lea…

review 2008
Cell research ·doi:10.1038/cr.2008.52

Ovarian cancer is a major health problem for women in the United States. Despite evidence of considerable heterogeneity, most cases of ovarian cancer are treated in a similar fashion. The molecular basis for the clinicopathologic characteri…